Table 3.
Prevalence of co-infections among patients from Xiangya Hospital Central South University, China, 2011–2016
| Co-infections | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | Total |
|---|---|---|---|---|---|---|---|
| Number(%) | Number(%) | Number(%) | Number(%) | Number(%) | Number(%) | Number(%) | |
| HBV-TP a | 181 (0.34) | 222 (0.35) | 230 (0.33) | 243 (0.31) | 202 (0.24) | 214 (0.23) | 1292 (0.29) |
| HBV-HCV a | 132 (0.25) | 135 (0.21) | 148 (0.21) | 138 (0.18) | 123 (0.15) | 129 (0.14) | 805 (0.18) |
| HCV-TP | 43 (0.08) | 39 (0.06) | 43 (0.06) | 38 (0.05) | 47 (0.06) | 57 (0.06) | 267 (0.06) |
| HIV-HBV a | 14 (0.03) | 16 (0.03) | 27 (0.04) | 34 (0.04) | 28 (0.03) | 48 (0.05) | 167 (0.03) |
| HIV-TP | 10 (0.02) | 19 (0.03) | 15 (0.02) | 21 (0.03) | 27 (0.03) | 32 (0.03) | 124 (0.03) |
| HIV-HCV | 4 (0.01) | 8 (0.01) | 3 (0.00) | 4 (0.01) | 8 (0.01) | 12 (0.01) | 39 (0.01) |
| HBV-HCV-TP | 14 (0.03) | 5 (0.01) | 16 (0.02) | 6 (0.01) | 5 (0.01) | 5 (0.01) | 51 (0.01) |
| HIV-HBV-TP | 1 (0.00) | 5 (0.01) | 5 (0.01) | 5 (0.01) | 4 (0.01) | 5 (0.01) | 25 (0.01) |
| HIV-HBV-HCV | 0 | 0 | 3 (0.00) | 3 (0.00) | 1 (0.00) | 4 (0.00) | 11 (0.00) |
| HIV-HCV-TP | 1 (0.00) | 0 | 2 (0.00) | 1 (0.01) | 1 (0.00) | 2 (0.00) | 7 (0.00) |
| HIV-HBV-HCV-TP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total a | 400 (0.74) | 449 (0.71) | 492 (0.70) | 493 (0.63) | 446 (0.53) | 508 (0.55) | 2788 (0.63) |
a: PHBV-TP:0.000(X2 = 13.709), PHBV-HCV:0.000(X2 = 21.044), PHIV-HBV:0.020(X2 = 5.426) PTotal:0.000(X2 = 20.382)